Monogram Orthopaedics (MGRM) Earnings Date, Estimates & Call Transcripts $2.05 +0.04 (+1.99%) (As of 11/15/2024 ET) Add Compare Share Share Earnings Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Monogram Orthopaedics Latest Earnings SummaryUpcoming Q3 Earnings DateNov. 19After Market ClosesConfirmedActual EPS (Aug. 15) -$0.11 Missed By -$0.02 Consensus EPS (Aug. 15) -$0.09 Monogram Orthopaedics posted Q2 2024 earnings on August 15, 2024, reporting an EPS of -$0.11, which missed analysts' consensus estimates of -$0.09 by $0.02. With a trailing EPS of -$0.47, Monogram Orthopaedics' earnings are expected to decrease next year, from ($0.45) to ($0.48) per share. Earnings Press ReleaseMGRM Upcoming EarningsMonogram Orthopaedics' next earnings date is scheduled for Tuesday, November 19, 2024. Get Monogram Orthopaedics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Monogram Orthopaedics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataMGRM Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.MGRM Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Monogram Orthopaedics Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20241-$0.12-$0.12-$0.12Q2 20241-$0.11-$0.11-$0.11Q3 20241-$0.10-$0.10-$0.10Q4 20241-$0.10-$0.10-$0.10FY 20244($0.43)($0.43)($0.43) Monogram Orthopaedics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks 11/19/2024(Confirmed)------- 8/15/2024Q2 2024-$0.09-$0.11 -$0.02-$0.11-- 5/13/2024Q1 2024-$0.12-$0.11+$0.01-$0.11-- 3/15/2024Q4 2023--$0.09 -$0.09-$0.09-$0.37M 11/8/2023Q3 2023--$0.03 -$0.03-$0.03--8/9/2023Q2 2023--$0.27 -$0.27-$0.27--6/6/2023Q1 2023--$0.40 -$0.40-$0.40-- Get the Latest News and Ratings for MGRM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monogram Orthopaedics and its competitors with MarketBeat's FREE daily newsletter. Monogram Orthopaedics Earnings - Frequently Asked Questions When is Monogram Orthopaedics's earnings date? Monogram Orthopaedics has confirmed that its next quarterly earnings data will be published on Tuesday, November 19th, 2024. Learn more on MGRM's earnings history. Did Monogram Orthopaedics beat their earnings estimates last quarter? In the previous quarter, Monogram Orthopaedics (NASDAQ:MGRM) missed the analysts' consensus estimate of ($0.09) by $0.02 with a reported earnings per share (EPS) of ($0.11). Learn more on analysts' earnings estimate vs. MGRM's actual earnings. How much revenue does Monogram Orthopaedics generate each year? Monogram Orthopaedics (NASDAQ:MGRM) has a recorded annual revenue of $364,999.00. How much profit does Monogram Orthopaedics generate each year? Monogram Orthopaedics (NASDAQ:MGRM) has a recorded net income of -$13.74 million. MGRM has generated -$0.47 earnings per share over the last four quarters. What is Monogram Orthopaedics's EPS forecast for next year? Monogram Orthopaedics's earnings are expected to decrease from ($0.45) per share to ($0.48) per share in the next year. ` More Earnings Resources from MarketBeat Related Companies NeuroPace Earnings Pulmonx Earnings Zynex Earnings Electromed Earnings Beauty Health Earnings Sight Sciences Earnings Profound Medical Earnings Nevro Earnings Alpha Tau Medical Earnings Pro-Dex Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?Apple Earnings - When Really Good Just Isn’t Good Enough Roblox Stock Set for More Gains After Strong Earnings ReportAmazon: Why Analysts Think It's a Solid Buy Ahead of EarningsLam Research Proves Analysts Wrong with a Strong Earnings ReportPulteGroup Earnings Signal Potential Entry Points for InvestorsTaiwan Semiconductor Soars on Earnings With More Room to Run JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. This page (NASDAQ:MGRM) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monogram Orthopaedics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monogram Orthopaedics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.